MCS

The Marcus Corporation

66
Fundamentals75/ 100
Valuation59/ 100
Upside potential78/ 100
Risk potential12/ 100

MCS has lower modeled downside risk, despite its lower overall score.

RDDT

Reddit, Inc.

70
Fundamentals88/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential41/ 100

RDDT has the edge over MCS overall, supported by stronger fundamentals.

MCS Fundamentals

MetricStatus
Healthy
Healthy
Healthy
Strong

MCS's revenue, profitability, cash flow and balance sheet are all currently healthy.

RDDT Fundamentals

MetricStatus
Healthy
Strong
Strong
Strong

RDDT's revenue, profitability, cash flow and balance sheet are all currently healthy.

MCS PE Valuation

CHEAPFAIREXPENSIVE395x789x1184x1579x
CHEAPFAIREXPENSIVE395x789x1184x1579x
LevelPEPriceVs current
Forward31x$27.22—
Cheap32x$24.94-8.4%
Current34x$27.22—
Fair42x$33.12+22%
Expensive429x$339+1145%

Historical ranges are pointers, not guarantees.

MCS's PE is in its cheap range at 34x. If earnings grow as analysts expect, today's price would be 31x next year's earnings.

RDDT PE Valuation

CHEAPFAIREXPENSIVE16x33x49x65x
CHEAPFAIREXPENSIVE16x33x49x65x
LevelPEPriceVs current
Forward16x$99.55—
Current20x$99.55—
Cheap35x$171+72%
Fair46x$228+129%
Expensive53x$262+163%

Historical ranges are pointers, not guarantees.

RDDT has the edge over MCS in the historical PE scenario, which offers more potential upside but is not a forecast.

MCS Forward outlook

MetricOutlook
Improving
Strong growth
Stable
Improving
Limited
Low

Analysts expect MCS's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.

RDDT Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
Low

RDDT has the edge over MCS on the outlook, with more favorable revenue expectations.

MCS Risk to reward

ScenarioChangePrice
Upside+42%$38.62
Downside-12%$24.00

Calculated from the latest close: $27.22 on Nov 12.

MCS has a better modeled risk to reward balance than RDDT, with more potential upside relative to its potential downside.

RDDT Risk to reward

ScenarioChangePrice
Upside+77%$175.99
Downside-41%$58.49

Calculated from the latest close: $99.55 on Nov 12.

RDDT trails MCS on modeled risk to reward, with less potential upside relative to its potential downside.

MCS Earnings Per Share

Q4 2023: $0.36Q1 2024: $0.29Q2 2024: $-0.67Q3 2024: $-0.24Q4 2024: $-0.24Q1 2025: $-0.40Q2 2025: $0.46Q3 2025: $0.25Q4 2025: $0.41Q1 2026: $0.44Q2 2026: $0.71Q3 2026: $0.79Forward: $0.87
Q4 2023: $0.36Q1 2024: $0.29Q2 2024: $-0.67Q3 2024: $-0.24Q4 2024: $-0.24Q1 2025: $-0.40Q2 2025: $0.46Q3 2025: $0.25Q4 2025: $0.41Q1 2026: $0.44Q2 2026: $0.71Q3 2026: $0.79Forward: $0.87
QuarterTTM EPSYoY
Forward$0.87+10%
Q3 2026$0.79+216%
Q2 2026$0.71+54%
Q1 2026$0.44+$0.84
Q4 2025$0.41+$0.65
Q3 2025$0.25+$0.49
Q2 2025$0.46+$1.13
Q1 2025-$0.40-238%
Q4 2024-$0.24-167%

MCS has the stronger earnings trend. Trailing diluted EPS is up 216% for MCS versus RDDT down 39%.

RDDT Earnings Per Share

Q4 2023: $-0.56Q1 2024: $-8.38Q2 2024: $-8.19Q3 2024: $-7.98Q4 2025: $2.62Q1 2026: $3.50Q2 2026: $4.30Q3 2026: $4.90Forward: $6.32
Q4 2023: $-0.56Q1 2024: $-8.38Q2 2024: $-8.19Q3 2024: $-7.98Q4 2025: $2.62Q1 2026: $3.50Q2 2026: $4.30Q3 2026: $4.90Forward: $6.32
QuarterTTM EPSYoY
Forward$6.32+29%
Q3 2024-$7.98-$7.17
Q2 2024-$8.19-$7.15
Q1 2024-$8.38-$7.25
Q4 2023-$0.56+$0.41
Q3 2023-$0.81-$0.02
Q2 2023-$1.04-$0.48
Q1 2023-$1.13-$0.48
Q4 2022-$0.97-$0.19

RDDT has returned to profit: it earned $4.90 per share over the past year, after losing money the year before.

MCS Quarterly Revenue

Q4 2023: $162MQ1 2024: $139MQ2 2024: $176MQ3 2024: $233MQ4 2024: $188MQ1 2025: $149MQ2 2025: $206MQ3 2025: $210MQ4 2025: $193MQ1 2026: $154MQ2 2026: $232MQ3 2026: $238M
Q4 2023: $162MQ1 2024: $139MQ2 2024: $176MQ3 2024: $233MQ4 2024: $188MQ1 2025: $149MQ2 2025: $206MQ3 2025: $210MQ4 2025: $193MQ1 2026: $154MQ2 2026: $232MQ3 2026: $238M
QuarterRevenueYoY
Q3 2026$237.8M+13%
Q2 2026$231.7M+12%
Q1 2026$154.4M+3.8%
Q4 2025$193.5M+2.8%
Q3 2025$210.2M-9.7%
Q2 2025$206M+17%
Q1 2025$148.8M+7.4%
Q4 2024$188.3M+17%

MCS's revenue has grown year over year for four quarters in a row: $238M last quarter, up 13% from the same quarter a year ago.

RDDT Quarterly Revenue

Q4 2023: $250MQ1 2024: $243MQ2 2024: $281MQ3 2024: $348MQ4 2024: $428MQ1 2025: $392MQ2 2025: $500MQ3 2025: $585MQ4 2025: $726MQ1 2026: $663MQ2 2026: $805MQ3 2026: $895M
Q4 2023: $250MQ1 2024: $243MQ2 2024: $281MQ3 2024: $348MQ4 2024: $428MQ1 2025: $392MQ2 2025: $500MQ3 2025: $585MQ4 2025: $726MQ1 2026: $663MQ2 2026: $805MQ3 2026: $895M
QuarterRevenueYoY
Q3 2026$895M+53%
Q2 2026$804.9M+61%
Q1 2026$663.4M+69%
Q4 2025$725.6M+70%
Q3 2025$584.9M+68%
Q2 2025$499.6M+78%
Q1 2025$392.4M+61%
Q4 2024$427.7M+71%

RDDT has the edge over MCS on sales, with more consistent year-over-year improvement.

MCS Free Cash Flow

Q4 2023: $21MQ1 2024: −$31MQ2 2024: $16MQ3 2024: $12MQ4 2024: $27MQ1 2025: −$58MQ2 2025: $15MQ3 2025: $18MQ4 2025: $26MQ1 2026: −$22MQ2 2026: $44MQ3 2026: $28M
Q4 2023: $21MQ1 2024: −$31MQ2 2024: $16MQ3 2024: $12MQ4 2024: $27MQ1 2025: −$58MQ2 2025: $15MQ3 2025: $18MQ4 2025: $26MQ1 2026: −$22MQ2 2026: $44MQ3 2026: $28M
QuarterFree cash flowYoY
Q3 2026$28.4M+56%
Q2 2026$44M+198%
Q1 2026-$21.9M+$36.5M
Q4 2025$26.4M-2.7%
Q3 2025$18.2M+51%
Q2 2025$14.7M-8.7%
Q1 2025-$58.3M-$27.8M
Q4 2024$27.1M+29%

MCS generated $77M in free cash flow over the past year, more than ten times what it generated the year before.

RDDT Free Cash Flow

Q4 2023: −$22MQ1 2024: $29MQ2 2024: $27MQ3 2024: $70MQ4 2024: $89MQ1 2025: $127MQ2 2025: $111MQ3 2025: $183MQ4 2025: $264MQ1 2026: $311MQ2 2026: $261MQ3 2026: $363M
Q4 2023: −$22MQ1 2024: $29MQ2 2024: $27MQ3 2024: $70MQ4 2024: $89MQ1 2025: $127MQ2 2025: $111MQ3 2025: $183MQ4 2025: $264MQ1 2026: $311MQ2 2026: $261MQ3 2026: $363M
QuarterFree cash flowYoY
Q3 2026$362.6M+98%
Q2 2026$260.7M+135%
Q1 2026$311.2M+146%
Q4 2025$263.6M+196%
Q3 2025$183.1M+161%
Q2 2025$110.8M+308%
Q1 2025$126.6M+333%
Q4 2024$89.2M+$111.2M

RDDT has the edge over MCS on cash flow, with more consistent year-over-year improvement.

MCS Total Shares

Q4 2023: 41MQ1 2024: 32MQ2 2024: 32MQ3 2024: 32MQ4 2024: 32MQ1 2025: 32MQ2 2025: 31MQ3 2025: 31MQ4 2025: 31MQ1 2026: 31MQ2 2026: 31MQ3 2026: 32M
Q4 2023: 41MQ1 2024: 32MQ2 2024: 32MQ3 2024: 32MQ4 2024: 32MQ1 2025: 32MQ2 2025: 31MQ3 2025: 31MQ4 2025: 31MQ1 2026: 31MQ2 2026: 31MQ3 2026: 32M
PeriodChange %Net change
Quarterly+1.5%+455K shares
1 year+1.1%+329K shares
3 years-23%-9.5M shares
5 years+0.3%+100K shares
Available history+1.1%+352K shares

MCS has 32M diluted shares, up 1.1% from a year ago.

RDDT Total Shares

Q4 2023: 163MQ1 2024: 70MQ2 2024: 164MQ3 2024: 192MQ1 2025: 201MQ2 2025: 200MQ3 2025: 203MQ4 2025: 202MQ1 2026: 203MQ2 2026: 202MQ3 2026: 202M
Q4 2023: 163MQ1 2024: 70MQ2 2024: 164MQ3 2024: 192MQ1 2025: 201MQ2 2025: 200MQ3 2025: 203MQ4 2025: 202MQ1 2026: 203MQ2 2026: 202MQ3 2026: 202M
PeriodChange %Net change
Quarterly-0.1%-169K shares
1 year-0.4%-868K shares
3 years+24%+38.5M shares
5 years+24%+38.5M shares

RDDT has the edge over MCS on shareholder dilution, with a more favorable share count trend.

MCS Net Leverage

Q4 2023: 1.1xQ1 2024: 1.6xQ2 2024: 1.9xQ3 2024: 1.7xQ4 2024: 1.4xQ1 2025: 2.3xQ2 2025: 1.8xQ3 2025: 1.9xQ4 2025: 1.6xQ1 2026: 1.8xQ2 2026: 1.2xQ3 2026: 0.8x
Q4 2023: 1.1xQ1 2024: 1.6xQ2 2024: 1.9xQ3 2024: 1.7xQ4 2024: 1.4xQ1 2025: 2.3xQ2 2025: 1.8xQ3 2025: 1.9xQ4 2025: 1.6xQ1 2026: 1.8xQ2 2026: 1.2xQ3 2026: 0.8x
QuarterNet LeverageStatus
Q3 20260.8xVery low
Q2 20261.2xHealthy
Q1 20261.8xHealthy
Q4 20251.6xHealthy
Q3 20251.9xHealthy
Q2 20251.8xHealthy
Q1 20252.3xModerate
Q4 20241.4xHealthy

MCS's net debt is less than a year of its operating earnings (EBITDA), down from 1.9 years a year ago.

RDDT Net Leverage

Q1 2025: -13.1xQ2 2025: -5.0xQ3 2025: -3.3xQ4 2025: -2.1xQ1 2026: -2.2xQ2 2026: -1.9xQ3 2026: -1.5x
Q1 2025: -13.1xQ2 2025: -5.0xQ3 2025: -3.3xQ4 2025: -2.1xQ1 2026: -2.2xQ2 2026: -1.9xQ3 2026: -1.5x
QuarterNet LeverageStatus
Q3 2026-1.5xNet Cash
Q2 2026-1.9xNet Cash
Q1 2026-2.2xNet Cash
Q4 2025-2.1xNet Cash
Q3 2025-3.3xNet Cash
Q2 2025-5.0xNet Cash
Q1 2025-13.1xNet Cash

RDDT has the edge over MCS on leverage, with a lower net debt burden relative to earnings.

MCS Weekly Momentum

MetricValueStatus
RSI58.6Neutral
Stochastic21.4Neutral

MCS's weekly RSI is 59 (neutral) and its Stochastic is 21 (neutral).

RDDT Weekly Momentum

MetricValueStatus
RSI34.8Neutral
Stochastic6.5Oversold

RDDT's weekly RSI is 35 (neutral) and its Stochastic is 6 (oversold).

MCS PE vs Communication Services Sector

MetricMCSSector medianRelative
PE34x16x109% above
PE %23263 pts below

MCS is trading at 34x earnings, a 109% premium to the Communication Services sector's median of 16x.

RDDT PE vs Communication Services Sector

MetricRDDTSector medianRelative
PE20x16x23% above
PE %52318 pts below

RDDT has the edge over MCS on valuation relative to its sector.

MCS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$27.30.4% below
20 week MA$27.10.6% above
50 week MA$21.328% above
100 week MA$19.242% above
200 week MA$17.159% above

MCS has stronger trend alignment. MCS is above 4 of 5 weekly averages versus RDDT above 0 of 4.

RDDT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$130.624% below
20 week MA$151.734% below
50 week MA$165.040% below
100 week MA$167.140% below

RDDT is in a downtrend: it's below all four of its weekly moving averages, and 40% below its 100-week average.

MCS Yearly ROI

YearStart priceEnd priceROI
2020$31.9$12.5-61%
2021$12.5$17.9+44%
2022$17.9$13.9-22%
2023$13.9$14.6+4.8%
2024$14.6$21.4+47%
2025$21.4$15.4-28%
2026 YTD$15.4$27.2+77%

MCS has the edge over RDDT on returns for 2026, with the stronger performance.

RDDT Yearly ROI

YearStart priceEnd priceROI
2024$46.0$173.5+277%
2025$173.5$225.8+30%
2026 YTD$225.8$99.6-56%

RDDT has finished every year since 2024 higher, and it's down 56% so far in 2026.

Give your agent the market.

Get API key